Search by Drug Name or NDC
NDC 57894-0450-01 TECVAYLI 90 mg/mL Details
TECVAYLI 90 mg/mL
TECVAYLI is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Biotech, Inc.. The primary component is TECLISTAMAB.
Product Information
| NDC | 57894-0450 |
|---|---|
| Product ID | 57894-450_02e74249-51cc-aa03-e063-6394a90af5ab |
| Associated GPIs | |
| GCN Sequence Number | 083976 |
| GCN Sequence Number Description | teclistamab-cqyv VIAL 153 MG/1.7 SUBCUT |
| HIC3 | V1K |
| HIC3 Description | ANTINEOPLASTICS ANTIBODY/ANTIBODY-DRUG COMPLEXES |
| GCN | 53055 |
| HICL Sequence Number | 048416 |
| HICL Sequence Number Description | TECLISTAMAB-CQYV |
| Brand/Generic | Brand |
| Proprietary Name | TECVAYLI |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | teclistamab |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 90 |
| Active Ingredient Units | mg/mL |
| Substance Name | TECLISTAMAB |
| Labeler Name | Janssen Biotech, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761291 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 57894-0450-01 (57894045001)
| NDC Package Code | 57894-450-01 |
|---|---|
| Billing NDC | 57894045001 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-450-01) / 1.7 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-10-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |